OBJECTIVE: Studies examining the link between objective measures of total daily physical activity and incident Alzheimer disease (AD) are lacking. We tested the hypothesis that an objective measure of total daily physical activity predicts incident AD and cognitive decline. METHODS: Total daily exercise and nonexercise physical activity was measured continuously for up to 10 days with actigraphy (Actical®; Philips Healthcare, Bend, OR) from 716 older individuals without dementia participating in the Rush Memory and Aging Project, a prospective, observational cohort study. All participants underwent structured annual clinical examination including a battery of 19 cognitive tests. RESULTS: During an average follow-up of about 4 years, 71 subjects developed clinical AD. In a Cox proportional hazards model adjusting for age, sex, and education, total daily physical activity was associated with incident AD (hazard ratio = 0.477; 95% confidence interval 0.273-0.832). The association remained after adjusting for self-report physical, social, and cognitive activities, as well as current level of motor function, depressive symptoms, chronic health conditions, and APOE allele status. In a linear mixed-effect model, the level of total daily physical activity was associated with the rate of global cognitive decline (estimate 0.033, SE 0.012, p = 0.007). CONCLUSIONS: A higher level of total daily physical activity is associated with a reduced risk of AD.
OBJECTIVE: Studies examining the link between objective measures of total daily physical activity and incident Alzheimer disease (AD) are lacking. We tested the hypothesis that an objective measure of total daily physical activity predicts incident AD and cognitive decline. METHODS: Total daily exercise and nonexercise physical activity was measured continuously for up to 10 days with actigraphy (Actical®; Philips Healthcare, Bend, OR) from 716 older individuals without dementia participating in the Rush Memory and Aging Project, a prospective, observational cohort study. All participants underwent structured annual clinical examination including a battery of 19 cognitive tests. RESULTS: During an average follow-up of about 4 years, 71 subjects developed clinical AD. In a Cox proportional hazards model adjusting for age, sex, and education, total daily physical activity was associated with incident AD (hazard ratio = 0.477; 95% confidence interval 0.273-0.832). The association remained after adjusting for self-report physical, social, and cognitive activities, as well as current level of motor function, depressive symptoms, chronic health conditions, and APOE allele status. In a linear mixed-effect model, the level of total daily physical activity was associated with the rate of global cognitive decline (estimate 0.033, SE 0.012, p = 0.007). CONCLUSIONS: A higher level of total daily physical activity is associated with a reduced risk of AD.
Authors: Joe Verghese; Richard B Lipton; Mindy J Katz; Charles B Hall; Carol A Derby; Gail Kuslansky; Anne F Ambrose; Martin Sliwinski; Herman Buschke Journal: N Engl J Med Date: 2003-06-19 Impact factor: 91.245
Authors: Ann M Harris; Lorraine M Lanningham-Foster; Shelly K McCrady; James A Levine Journal: Am J Physiol Endocrinol Metab Date: 2007-04 Impact factor: 4.310
Authors: Eric B Larson; Li Wang; James D Bowen; Wayne C McCormick; Linda Teri; Paul Crane; Walter Kukull Journal: Ann Intern Med Date: 2006-01-17 Impact factor: 25.391
Authors: Andrew S P Lim; Lei Yu; Madalena D Costa; Aron S Buchman; David A Bennett; Sue E Leurgans; Clifford B Saper Journal: Sleep Date: 2011-11-01 Impact factor: 5.849
Authors: Andrew S P Lim; Lei Yu; Madalena D Costa; Sue E Leurgans; Aron S Buchman; David A Bennett; Clifford B Saper Journal: Sleep Date: 2012-05-01 Impact factor: 5.849
Authors: Aron S Buchman; Robert S Wilson; Patricia A Boyle; Julia L Bienias; David A Bennett Journal: J Am Geriatr Soc Date: 2007-01 Impact factor: 5.562
Authors: David A Bennett; Julie A Schneider; Aron S Buchman; Carlos Mendes de Leon; Julia L Bienias; Robert S Wilson Journal: Neuroepidemiology Date: 2005-08-15 Impact factor: 3.282
Authors: Jennifer S Brach; Shannon FitzGerald; Anne B Newman; Sheryl Kelsey; Lewis Kuller; Jessie M VanSwearingen; Andrea M Kriska Journal: Arch Intern Med Date: 2003-11-24
Authors: Wenfei Zhu; Virginia J Howard; Virginia G Wadley; Brent Hutto; Steven N Blair; John E Vena; Natalie Colabianchi; David Rhodes; Steven P Hooker Journal: J Am Geriatr Soc Date: 2015-12 Impact factor: 5.562
Authors: Joshua Z Willey; Yeseon Park Moon; Rachel Ruder; Yuen K Cheung; Ralph L Sacco; Mitchell S V Elkind; Clinton B Wright Journal: Neuroepidemiology Date: 2013-12-03 Impact factor: 3.282
Authors: Renée F A G de Bruijn; Elisabeth M C Schrijvers; Karen A de Groot; Jacqueline C M Witteman; Albert Hofman; Oscar H Franco; Peter J Koudstaal; Mohammad Arfan Ikram Journal: Eur J Epidemiol Date: 2013-02-06 Impact factor: 8.082
Authors: Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Neurol Sci Date: 2014-02-18 Impact factor: 3.181
Authors: Lei Yu; Patricia A Boyle; Eisuke Segawa; Sue Leurgans; Julie A Schneider; Robert S Wilson; David A Bennett Journal: Neuropsychology Date: 2014-12-15 Impact factor: 3.295
Authors: Aner Weiss; Anat Mirelman; Nir Giladi; Lisa L Barnes; David A Bennett; Aron S Buchman; Jeffrey M Hausdorff Journal: J Am Med Dir Assoc Date: 2016-09-01 Impact factor: 4.669
Authors: Krysten K Fulcher; Michael L Alosco; Lindsay Miller; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: Health Psychol Date: 2014-01-27 Impact factor: 4.267